Tag: New drug approvals

Novel Drug siRNA that lowers hypercholesterolemia in patients with gene disorder heterozygous familial hypercholesterolemia (HeFH) or clinical atherosclerotic cardiovascular disease (ASCVD)

Novel drug for hypercholesterolemia which is a SiRNA is now approved by USFDA for heterozygous familial hypercholesterolemia associated with genetic disorder. Drug (inclisiran)  injection of Novartis a silensing RNA inhibits the process of translation of protein so that faulty enzyme production stops which is responsible for lipid production and hyperlipidemia. Basic constituent of the human […]

%d bloggers like this: